Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Biochemical and Biophysical Research Communications
|
June 20, 2014
Estradiol determines the effects of PTH on ERα-dependent transcription in MC3T3-E1 cells
Monika H E Christensen, Ingvild S Fenne, Marianne H Flågeng, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 31, 2003
Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation
Pål I Holm, Øyvind Bleie, Per M Ueland, et al.
The American Journal of Clinical Nutrition
|
September 28, 2004
Phenotypic expression of the methylenetetrahydrofolate reductase 677C-->T polymorphism and flavin cofactor availability in thyroid dysfunction
Steinar Hustad, Bjørn G Nedrebø, Per Magne Ueland, et al.
Plos One
|
June 24, 2011
Primary hyperparathyroidism influences the expression of inflammatory and metabolic genes in adipose tissue
Monika H E Christensen, Simon N Dankel, Yngve Nordbø, et al.
BMC Cancer
|
June 23, 2010
Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer
Jennifer Gjerde, Jürgen Geisler, Steinar Lundgren, et al.
Breast Cancer Research and Treatment
|
May 8, 2012
Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide
Jennifer Gjerde, Sara Gandini, Aliana Guerrieri-Gonzaga, et al.
BMC Cancer
|
June 19, 2012
Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer
Line L Haugan Moi, Marianne Hauglid Flågeng, Jennifer Gjerde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2004
Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial
Elton R Kisanga, Jennifer Gjerde, Aliana Guerrieri-Gonzaga, et al.
European Journal of Endocrinology
|
November 26, 2002
Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease
Bjorn G Nedrebo, Pal I Holm, Sverre Uhlving, et al.
Plos One
|
April 14, 2015
The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells
Thomas Helland, Jennifer Gjerde, Simon Dankel, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Biochemical and Biophysical Research Communications
|
June 20, 2014
Estradiol determines the effects of PTH on ERα-dependent transcription in MC3T3-E1 cells
Monika H E Christensen, Ingvild S Fenne, Marianne H Flågeng, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 31, 2003
Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation
Pål I Holm, Øyvind Bleie, Per M Ueland, et al.
The American Journal of Clinical Nutrition
|
September 28, 2004
Phenotypic expression of the methylenetetrahydrofolate reductase 677C-->T polymorphism and flavin cofactor availability in thyroid dysfunction
Steinar Hustad, Bjørn G Nedrebø, Per Magne Ueland, et al.
Plos One
|
June 24, 2011
Primary hyperparathyroidism influences the expression of inflammatory and metabolic genes in adipose tissue
Monika H E Christensen, Simon N Dankel, Yngve Nordbø, et al.
BMC Cancer
|
June 23, 2010
Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer
Jennifer Gjerde, Jürgen Geisler, Steinar Lundgren, et al.
Breast Cancer Research and Treatment
|
May 8, 2012
Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide
Jennifer Gjerde, Sara Gandini, Aliana Guerrieri-Gonzaga, et al.
BMC Cancer
|
June 19, 2012
Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer
Line L Haugan Moi, Marianne Hauglid Flågeng, Jennifer Gjerde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2004
Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial
Elton R Kisanga, Jennifer Gjerde, Aliana Guerrieri-Gonzaga, et al.
European Journal of Endocrinology
|
November 26, 2002
Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease
Bjorn G Nedrebo, Pal I Holm, Sverre Uhlving, et al.
Plos One
|
April 14, 2015
The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells
Thomas Helland, Jennifer Gjerde, Simon Dankel, et al.
Page
of 3